How Do E-Cigarettes Cause Lung Disease?

Respiratory diseases are leading causes of illness and death worldwide, with smoking currently their most important cause. Like tobacco products, electronic cigarettes expose users to nicotine, ultrafine particles, and other toxic components. Some lung-toxic substances—propylene glycol, diacetyl, butter flavor, cinnamaldehyde, cinnamon flavor, benzaldehyde, cherry flavor, and metals—occur at higher levels than in cigarettes. A December 2019 article by a team including leading tobacco researcher Stanton A. Glantz discussed animal findings and observational human data. E-cigarettes suppress the immune response while increasing lung inflammatory reactions and oxidative stress. Oxidative stress is disrupted balance caused by increased reactive oxygen species (ROS), such as hydroxyl and superoxide radicals and hydrogen peroxide formed in metabolism, with inadequate detoxification. Interaction of propylene glycol and glycerin in cartridge liquids produces acrolein. Repeated exposure causes lung inflammation, reduced defenses, activated neutrophils, excess mucus, and tissue damage—mechanisms also causing Chronic Obstructive Pulmonary Disease (COPD). Mouse experiments also show vaping suppresses lung defense against viruses and bacteria. Consistent human findings show inhibited immune gene expression in vapers' nasal cavities, exceeding that in smokers. Airways contain innate defense proteins; vaping adversely alters their profiles similarly to smoking. Biologically consistent studies associate vaping with emphysema, chronic bronchitis, and COPD in children and adults.
Study Highlights
• This first broad population-based analysis of vaping and respiratory disease shows increased likelihood of developing respiratory disease.
• The risks arising from e-cigarette use are independent of risks caused by conventional cigarettes and occur in addition to those cigarette-related risks.
• Findings combine animal and human studies.
• Vaping is associated with and increases emphysema, chronic bronchitis, and COPD likelihood.
• Longitudinal rather than cross-sectional assessment produced much stronger results.
• Another strength was reassessment and diagnostic information collected 1 year after diagnoses of respiratory diseases occurring years after e-cigarettes entered the market.
In conclusion, vaping increases respiratory disease risk independently of and in addition to tobacco products. Switching entirely from all tobacco, including cigarettes, might theoretically reduce risk, but evidence indicates the opposite given widespread dual use and increased disease. The authors' final emphasis was “e-cigarettes should not be recommended” .
Sources
Association of E-Cigarette Use With Respiratory Disease Among Adults: A Longitudinal Analysis
American Journal of Preventive Medicine, 16 December 2019.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.